Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1969 Aug 23;101(4):231–234.

Hodgkin's disease complicated by infection with Mycobacterium kansasii.

J Harris, R Alexanian, E M Hersh, W Leary
PMCID: PMC1946123  PMID: 5811703

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C. IMMUNOLOGIC ASPECTS OF HODGKIN'S DISEASE. Medicine (Baltimore) 1964 May;43:189–193. doi: 10.1097/00005792-196405000-00001. [DOI] [PubMed] [Google Scholar]
  2. CORPE R. F., RUNYON E. H., LESTER W. Status of disease due to unclassified mycobacteria. A statement of the Subcommittee on Unclassified Mycobacteria of the Committee on Therapy. Am Rev Respir Dis. 1963 Mar;87:459–461. doi: 10.1164/arrd.1963.87.3P1.459. [DOI] [PubMed] [Google Scholar]
  3. Casazza A. R., Duvall C. P., Carbone P. P. Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1290–1296. [PubMed] [Google Scholar]
  4. Chase M. W. Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis. Cancer Res. 1966 Jun;26(6):1097–1120. [PubMed] [Google Scholar]
  5. Hersh E. M., Harris J. E. Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes. J Immunol. 1968 Jun;100(6):1184–1194. [PubMed] [Google Scholar]
  6. KLINENBERG J. R., GRIMLEY P. M., SEEGMILLER J. E. DESTRUCTIVE POLYARTHRITIS DUE TO A PHOTOCHROMOGENIC MYCOBACTERIUM. N Engl J Med. 1965 Jan 28;272:190–193. doi: 10.1056/NEJM196501282720405. [DOI] [PubMed] [Google Scholar]
  7. Oppenheim J. J. Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man. Fed Proc. 1968 Jan-Feb;27(1):21–28. [PubMed] [Google Scholar]
  8. RAZIS D. V., DIAMOND H. D., CRAVER L. F. Hodgkin's disease associated with other malignant tumors and certain non-neoplastic diseases. Am J Med Sci. 1959 Sep;238:327–335. doi: 10.1097/00000441-195909000-00009. [DOI] [PubMed] [Google Scholar]
  9. Sohier W. D., Jr, Wong R. K., Aisenberg A. C. Vinblastine in the treatment of advanced Hodgkin's disease. Cancer. 1968 Aug;22(2):467–472. doi: 10.1002/1097-0142(196808)22:2<467::aid-cncr2820220226>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  10. Swanson M. A., Schwartz R. S. Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med. 1967 Jul 27;277(4):163–170. doi: 10.1056/NEJM196707272770401. [DOI] [PubMed] [Google Scholar]
  11. Waldorf D. S., Willkens R. F., Decker J. L. Impaired delayed hypersensitivity in an aging population. Association with antinuclear reactivity and rheumatoid factor. JAMA. 1968 Mar 4;203(10):831–834. [PubMed] [Google Scholar]
  12. Zamorano J., Jr, Tompsett R. Disseminated atypical mycobacterial infection and pancytopenia. Arch Intern Med. 1968 May;121(5):424–427. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES